Heramed Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor principally for use by an expectant mother to monitor their fetus' heartbeat. It is also involved in developing EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Sydney, Australia.
|Primary activities||Development, manufacture and distribution of fetal heart beat monitors and other pregnancy-related solutions.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||23-25 Hunter Street Suite 3 Level 10 Sydney NSW 2000 Australia|
|Phone / Fax||61 2 8379 2961 /|
|Share registry||AUTOMIC REGISTRY SERVICES|
Heramed does not pay dividends.
As of May 2021, following are the company executives and directors listed on Heramed.
|Mr. David Groberman||Co-Founder, CEO & Exec. Director||211.91k|
|Mr. Tal Slonim||Co-Founder, COO & Exec. Director||58.3k|
|Ms. Sivan Sadan||Chief Financial Officer||127.22k|
|Mr. Michael Nenner||Chief Technology Officer|
|Henry Jordan||Head of Investor Relations|
|Mr. Ariel Laden||VP of Marketing|
|Dr. Josef Tovbin||Chief Medical Officer|
|Mr. Jonathan Hart B.Com., L.L.B.||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Heramed is 25.61M and its enterprise value is 25.52M. The enterprise value to revenue ratio of HMD is 645.84.
Companies similar to Heramed (HMD)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Heramed (ASX:HMD) Frequently Asked Questions
1. What is Heramed's Stock Symbol?
Heramed trades on ASX under the ticker symbol "HMD".
2. What is Heramed's stock price today?
One share of HMD stock can currently be purchased for approximately $0.145.
3. How can I contact Heramed?
Heramed's mailing address is 23-25 Hunter Street Suite 3 Level 10 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 8379 2961.
4. What is Heramed's official website?
The official website of Heramed is http://www.hera-med.com.
5. Which share registry manages Heramed's stock?
Heramed's stock is managed by AUTOMIC REGISTRY SERVICES.